Source:http://linkedlifedata.com/resource/pubmed/id/10580906
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1999-12-30
|
pubmed:abstractText |
A 10-year-old, female shih tzu was diagnosed as having myelodysplastic syndrome (MDS) based on the presence of a nonregenerative anemia, dysplastic changes in the three hematopoietic cell lines, a normal to hypercellular bone marrow, and less than 30% blast cells of all nucleated cells in the bone marrow. Low-dose aclarubicin, a differentiation-induction therapy for MDS and atypical leukemias in humans, was administered. Hematological improvement was observed, and the dog lived for 809 days after the first presentation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0587-2871
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
475-81
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10580906-Aclarubicin,
pubmed-meshheading:10580906-Animals,
pubmed-meshheading:10580906-Antibiotics, Antineoplastic,
pubmed-meshheading:10580906-Biopsy, Needle,
pubmed-meshheading:10580906-Bone Marrow,
pubmed-meshheading:10580906-Chronic Disease,
pubmed-meshheading:10580906-Dog Diseases,
pubmed-meshheading:10580906-Dogs,
pubmed-meshheading:10580906-Fatal Outcome,
pubmed-meshheading:10580906-Female,
pubmed-meshheading:10580906-Injections, Intravenous,
pubmed-meshheading:10580906-Myelodysplastic Syndromes
|
pubmed:articleTitle |
Long-term case study of myelodysplastic syndrome in a dog.
|
pubmed:affiliation |
Department of Veterinary Medicine, College of Agriculture, Osaka Prefecture University, Sakai, Japan.
|
pubmed:publicationType |
Journal Article,
Case Reports
|